Atrial Fibrillation and Stable Coronary Artery Disease

被引：0
|
作者：
Lip, Gregory Y. H. [1 ,2 ]
机构：
[1] Liverpool John Moores Univ, Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[2] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 22期
关键词：
D O I：
10.1056/NEJMe2409696
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2159 / 2161
页数：3
相关论文
共 50 条
  • [31] Atrial fibrillation in coronary artery disease: role of atrial enlargement and ischaemia
    Wang, LX
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 75 (2-3) : 309 - 310
  • [32] Antithrombotic Therapy for Atrial Fibrillation and stable coronary Heart Disease
    Dovjak, Peter
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2019, 52 (08): : 808 - 809
  • [33] Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease
    Otterstad, Jan Erik
    Kirwan, Bridget-Anne
    Lubsen, Jacobus
    De Brouwer, Sophie
    Fox, Keith A. A.
    Corell, Pernille
    Poole-Wilson, Philip A.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2006, 40 (03) : 152 - 159
  • [34] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease REPLY
    Yasuda, Satoshi
    Ogawa, Hisao
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2481 - 2481
  • [35] Correlates and outcome of atrial fibrillation in stable symptomatic coronary disease
    Otterstad, J. E.
    Kirwan, B. -A.
    Lubsen, J.
    De Brouwer, S.
    Fox, K. A. A.
    Hildebrandt, P.
    Poole-Wilson, P. A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 882 - 882
  • [36] Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease
    Burnham, Tyson S.
    May, Heidi T.
    Bair, Tami L.
    Anderson, Jeffrey A.
    Crandall, Brian G.
    Cutler, Michael J.
    Day, John D.
    Freedman, Roger A.
    Knowlton, Kirk U.
    Muhlestein, Joseph B.
    Navaravong, Leenhapong
    Ranjan, Ravi A.
    Steinberg, Benjamin A.
    Bunch, T. Jared
    AMERICAN HEART JOURNAL, 2022, 243 : 127 - 139
  • [37] Should patients with atrial fibrillation and stable coronary artery disease receive an oral anticoagulant, an antiplatelet or both?
    Mills, Mark T.
    BMJ EVIDENCE-BASED MEDICINE, 2021, 26 (06) : E13 - +
  • [38] Identification of potential biomarkers for atrial fibrillation and stable coronary artery disease based on WGCNA and machine algorithms
    Wu, Ke
    Chen, Hao
    Li, Fan
    Meng, Xiangjuan
    Chen, Lin
    Li, Nannan
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [39] New oral anticoagulants for nonvalvular atrial fibrillation with stable coronary artery disease: A meta-analysis
    Cen, Zhifu
    Meng, Qiuyu
    Cui, Kaijun
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (11): : 1393 - 1400
  • [40] Long-Term Outcomes in Patients Treated With Flecainide for Atrial Fibrillation With Stable Coronary Artery Disease
    Bunch, Thomas J.
    May, Heidi T.
    Cruz, Jalisa
    Bair, Tami L.
    Weiss, J. Peter
    Day, John D.
    Crandall, Brian
    Cutler, Michael J.
    Osborn, Jeffrey S.
    Mallender, Charles
    Anderson, Jeffrey L.
    Muhlestein, Joseph B.
    Knowlton, Kirk U.
    CIRCULATION, 2019, 140
12345